D-ery­thro-sphin­go­sine-1-phos­phate CAS 26993-30-6

• Iden­ti­fi­ca­tion
• Prop­er­ties
• Safe­ty Data
• Spec­i­fi­ca­tions & Oth­er Information
• Links
• Quick Inquiry

Iden­ti­fi­ca­tion

CAS Number

26993-30-6

Name

D-ery­thro-sphin­­­go­­sine-1-phos­phate ; S1P

Syn­onyms

(4E)-2-Amino-3-hydroxy-4-octade­cen-1-yl dihy­dro­gen phosphate

[IUPAC name – gen­er­at­ed by ACD/​Name]
(4E)-2-Amino-3-hydroxy-4-octade­cen-1-yldihy­dro­gen-phos­phat

(4E)-2-Amino-3-hydroxy-4-octade­cen-1-yldihy­dro­gen­phos­phat

[Ger­man]

[IUPAC name – gen­er­at­ed by ACD/​Name]
(4E)-2-amino-3-hydrox­y­oc­tadec-4-en-1-yl dihy­dro­gen phosphate

26993-30-6

[RN]
4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phos­phate), (4E)-

[IUPAC index name – gen­er­at­ed by ACD/​Name]
Dihy­drogène phos­phate de (4E)-2-amino-3-hydroxy-4-octadécèn-1-yle

Dihy­drogénophos­phate de (4E)-2-amino-3-hydroxy-4-octadécén-1-yle

[French]

[IUPAC name – gen­er­at­ed by ACD/​Name]
Sphin­go­sine 1-phosphate

Sphin­­­go­­sine-1-phos­phate

SMILES

CCC­C­C­C­C­C­C­C­C­CC/C=C/C(O)C(N)COP(=O)(O)O

Std­InChI

InChI=1S/C18H38NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h14-15,17-18,20H,2-13,16,19H2,1H3,(H2,21,22,23)/b15-14+

Std­InChIKey

DUYSYHSS­B­D­VJSM-CCEZHUS­R­SA-N

Mol­e­c­u­lar Formula

C18H38NO5P

Mol­e­c­u­lar Weight

379.478

MDL Number

MFCD00270077

Prop­er­ties

Appear­ance

White to light yel­low powder

Safe­ty Data

Sym­bol

Sig­nal Word

Warn­ing

WGK Germany

3

MSDS Download

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our D-ery­thro-sphin­­­go­­sine-1-phos­phate CAS 26993-30-6

Iden­ti­fi­ca­tion Methods

HNMR, HPLC

Puri­ty

98% min

Shelf Life

1 year

Stor­age

Stor­age at -20°.

Known Appli­ca­tion

1.Signal Mol­e­cule Research -Acts as a potent extra­cel­lu­lar sig­nal­ing lipid. -Binds to S1P recep­tors (S1PR1 – 5) and reg­u­lates cell migra­tion, pro­lif­er­a­tion, dif­fer­en­ti­a­tion, vas­cu­lar devel­op­ment, and immune cell traf­fick­ing. 2. Phar­ma­co­log­i­cal Research -Involved in immune reg­u­la­tion, can­cer pro­gres­sion, car­dio­vas­cu­lar dis­eases, and inflam­ma­tion. -Basis for ther­a­peu­tic devel­op­ment (e.g., Fingolimod/​Gilenya®, an S1P recep­tor mod­u­la­tor for mul­ti­ple scle­ro­sis). 3. Research Reagent – Com­mon­ly used in cell sig­nal­ing stud­ies, lipid metab­o­lism research, and immunol­o­gy exper­i­ments. – Applied to study S1P-S1PR path­ways in inflam­ma­tion, tumor metas­ta­sis, and angio­gen­e­sis. 4. Poten­tial Appli­ca­tions -Inves­ti­gat­ed as a drug tar­get or tool com­pound for autoim­mune dis­eases, ath­er­o­scle­ro­sis, asth­ma, and can­cer therapy.

Gen­er­al View of Documents

Links

This prod­uct is devel­oped by our R&D com­pa­ny Ulcho Bio­chem­i­cal Lim­it­ed (http://​www​.ulcho​.com/).

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly.